NASDAQ: SXTC
China Sxt Pharmaceuticals Inc Stock Ownership - Who owns China Sxt Pharmaceuticals?

Insider buying vs selling

Have China Sxt Pharmaceuticals Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when SXTC insiders and whales buy or sell their stock.

SXTC Shareholders

What type of owners hold China Sxt Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Citadel Advisors LLC19.47%150,576$326.75kInstitution
Invesco Ltd11.03%85,331$185.17kInstitution
Geode Capital Management LLC6.94%53,671$116.47kInstitution
Xtx Topco Ltd2.94%22,774$49.42kInstitution
Virtu Financial LLC1.60%12,355$26.81kInstitution
Tower Research Capital LLC Trc0.24%1,827$3.96kInstitution
Royal Bank Of Canada0.11%818$1.78kInstitution
Ubs Group Ag0.03%222$481.74Institution

1 of 1

SXTC vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SXTC42.35%0.00%
SHPH1.21%98.79%
UPC0.17%0.00%
PRFX16.13%0.00%
KALA5.27%94.73%Net Selling

China Sxt Pharmaceuticals Stock Ownership FAQ

Who owns China Sxt Pharmaceuticals?

China Sxt Pharmaceuticals (NASDAQ: SXTC) is owned by 42.35% institutional shareholders, 0.00% China Sxt Pharmaceuticals insiders, and 57.65% retail investors. Citadel Advisors LLC is the largest individual China Sxt Pharmaceuticals shareholder, owning 150,576.00 shares representing 19.47% of the company. Citadel Advisors LLC's China Sxt Pharmaceuticals shares are currently valued at $320.73k.

If you're new to stock investing, here's how to buy China Sxt Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.